Laninamivir octanoate

DB11888InvestigationalSmall molecule

Laninamivir octanoate has been used in trials studying the treatment of Asthma.

Chemical structure of Laninamivir octanoate
Mechanism
Curator reviewed
Formula / weight
C21H36N4O8 · 472.5325 g/mol (avg)
Code names
CS-8958 · R-118958

Resolves to

Compound
UNIIE026V904RLCAS203120-46-1ChEMBLCHEMBL467058ChEBI134741PubChem9847629
Structure
InChIKeyUKTIJASCFRNWCB-RMIBSVFLSA-NSMILES[H][C@]1(OC(=C[C@H](NC(N)=N)[C@H]1NC(C)=O)C(O)=O)[C@H](OC)[C@H](O)COC(=O)CCCCCCC
Targets
P03474NA

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
14Drug interactionsStructured to mechanism, not free text
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Laninamivir octanoate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In